Navigation Links
BioImagene Raises $26 M in Expansion Capital
Date:8/19/2008

BioImagene, the leading provider of affordable digital pathology solutions for cancer diagnosis and preclinical research, today announced the closing of a $26 million series D financing round led by Burrill & Company. Ascension Health Ventures, National Healthcare Services and existing investors Artiman Ventures and ICCP Ventures also joined the round with strong support.

CUPERTINO, Calif. (Business Wire EON) August 19, 2008 -- Mr. Yatin Mundkur, Artiman Ventures Partner and BioImagene board member noted "This follow-on investment reaffirms our commitment to the BioImagene team and their innovative products, and reinforces our belief in the enormous growth potential of digital pathology. We are very happy to guide the company through their next phase of future growth."

BioImagene CEO Mohan Uttarwar commented, "This latest infusion of capital from leading investors is a strong vote of confidence in our team, products and strategy. Our goal is to become the dominant player in this space by 2010. We are within range of our target and this funding will help us scale operations to support the rapidly increasing demand for affordable, integrated digital pathology systems. "

Digital pathology is the process of converting entire glass microscope slides into high-resolution, whole-slide digital images that can be viewed, managed and analyzed with a computer instead of a microscope—along with digital pathology management systems that help interpret the information generated from the digitized glass slide.

Digital pathology applications utilizing digital slides are gaining momentum as pathologists can access slide specimens and related data from any location in the world, fostering more efficient laboratory workflow, physician communication, education and research at a reasonable cost.

Investor Information

For more information on Artiman Ventures, please visit www.artimanventures.com

For more information on Ascension Health Ventures, please visit www.ascensionhealthventures.org

For more information on Burrill & Company, please visit www.burrillandco.com

For more information on National Healthcare Services (NHS), please visit www.nationalhealthcareservices.com

For more information on ICCP Ventures, please visit www.iccpventurepartners.com

About BioImagene

BioImagene is a leading provider of total digital pathology solutions for applications including clinical diagnostics and drug discovery. BioImagene products are FDA -cleared for specific clinical applications, and are intended for research use for other applications. www.bioimagene.com.

Read the full story at http://www.prweb.com/releases/bioimagene/ventures/prweb1227644.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Low Vitamin D Raises Womens Hip Fracture Risk
2. NJHA Raises Questions Regarding Horizons Proposal to Convert to For-Profit Health Insurer
3. Stater Bros. Raises $200,000 for the Leukemia & Lymphoma Society
4. Summer Games Swap Raises Questions About Image, Oral Health
5. Dunkin Donuts Event Raises $800,000 for Cancer Research in One Day
6. The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance
7. GI Bleeding After Stroke Raises Death Risk
8. Aduromed Closes Restructuring and Raises $3.8 Million of New Equity Capital
9. Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008
10. Secondhand Smoke Raises Stroke Risk for Spouses
11. CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 BioImagene Raises $26 M in Expansion Capital 
(Date:2/18/2017)... ... February 18, 2017 , ... ProParagraph Fashion ... Film Studios ’ ProParagraph Fashion Volume 2 for all multi-line FCPX project needs. ... Users can pick and choose from hand-crafted trend-setting designs with smooth animations that ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Alliance Healthcare ... designed to further positively impact the health and wellness of our community in ... it our duty to seriously consider releasing our assets beyond our 5% targeted ...
(Date:2/17/2017)... Palos Verdes, CA (PRWEB) , ... February 17, ... ... and emotional flow is Dr. Carol Francis' goals for each and ... Retreat Conference, Dr. Carol Francis will demonstrate five different brainwave tools which help ...
(Date:2/17/2017)... ... 2017 , ... Program will serve more than 5,000 kids ... Soccer Foundation announced today that they have awarded nine grants to expand the ... soccer mentoring program, teaches kids the fundamentals of soccer while striving to help ...
(Date:2/17/2017)... ... 17, 2017 , ... Cancer diagnostics workflow solution provider Inspirata, ... – 22 in San Francisco. As part of the Tri-Conference expo, which is ... solution, as well as its new precision medicine platform, “Crosswalk Insight: Oncology™.” , ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Feb. 17, 2017  Perrigo Company plc (NYSE, TASE: PRGO) today ... and Drug Administration for hydrocodone bitartrate and homatropine methylbromide oral ... Hydrocodone bitartrate and homatropine methylbromide oral solution (syrup), 5 ... relief of cough in adults and children 6 years of ... January 2017 were approximately $16 million.   ...
(Date:2/17/2017)... , Feb 17, 2017 Research and Markets has ... Report" report to their offering. ... The report provides separate comprehensive analytics for the US, ... , Asia-Pacific , Latin America , ... period 2015 through 2022. Also, a six-year historic analysis is provided for ...
(Date:2/17/2017)... 17, 2017  In partnership with CitiHope , ... Health , The Jack Brewer Foundation (JBF ... of dollars, worth of medicine to Innovating Health ... IHI is a non-profit dedicated to treating chronic diseases and addressing ... in Haiti and providing these ...
Breaking Medicine Technology: